Improving lives and health outcomes.
Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience.
At Ipsen, we’re dedicated to improving people’s lives and health outcomes. Our 5,700 employees around the world are committed to tackling areas of high unmet medical need to improve the quality of life of patients and caregivers.
65 Quai Georges Gorse, 92100 Boulogne-Billancourt – France
Dec. 6, 2005Stock exchange(s)